UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |--------------- ...

Bio-Path Holdings, Inc (NASDAQ:BPTH) Q4 2020 Earnings Conference Call March 10, 2021 8:30 AM ET Company Participants Will O'Connor - Stern IR Peter Nielsen - President and CEO Anthony Price - SVP of Finance, Accounting, and Administration Conference Call Participants Yi Chen - H.C. Wainwright Jonathan Aschoff - ROTH Capital Partners Laura Engle - Stonegate Capital Partners Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings' Full-Year 2020 Earnings Conference Call. At this time, al ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 87-0652870 (State or other jurisdiction of incorporation (I.R.S. Employer Identification No.) or organization) 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401 (Address of principal executive offices) (Zip Code) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital Market FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 O ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2020 Earnings Conference Call November 13, 2020 8:30 AM ET Company Participants Will O’Connor – Stern Investor Relations Peter Nielsen – President and Chief Executive Officer Anthony Price – Senior Vice President-Finance, Accounting and Administration Conference Call Participants Boobalan Pachaiyappan – H.C. Wainwright Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings’ Third Quarter 2020 Earnings Conference Call. At this time, all particip ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |----------- ...

Bio-Path Holdings Inc (NASDAQ:BPTH) Q2 2020 Results Conference Call August 14, 2020 8:30 AM ET Company Participants Will O’Connor - Stern Investor Relations Peter Nielsen - President, Chief Executive Officer and Chief Financial Officer Anthony Price - Senior Vice President of Finance, Accounting and Administration Conference Call Participants Laura Ingalls - Stone Gate Capital Partners Yi Chen - H.C. Wainwright Operator Ladies and gentlemen, good morning, and welcome to the Bio-Path Holdings Second Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | | ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2020 Results Earnings Conference Call May 15, 2020 8:30 AM ET Company Participants Will O'Connor - Investor Relations, Stern Investor Relations Peter Nielsen - President, Chief Executive Officer and Chief Financial Officer Anthony Price - Senior Vice President of Finance, Accounting and Administration Conference Call Participants Yi Chen - H.C. Wainwright & Co. Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings First Quarter 2020 Earnings C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 87-0652870 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital Market FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Or ¨ TRANSITIO ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2019 Earnings Conference Call March 6, 2020 8:30 AM ET Company Participants Will O'Connor - Stern IR Peter Nielsen - President & CEO Anthony Price - VP, Finance & Accounting Conference Call Participants Yi Chen - H.C. Wainwright Laura Engle - Stonegate Capital Partners Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings Year End 2019 Earnings Conference Call. At this time, all participants are in listen-only mode. Following the formal remark ...